Literature DB >> 7542547

Direct physical interaction involving CD40 ligand on T cells and CD40 on B cells is required to propagate MMTV.

A V Chervonsky1, J Xu, A K Barlow, M Khery, R A Flavell, C A Janeway.   

Abstract

The propagation of mouse mammary tumor virus (MMTV) has been analyzed in mice defective for expression of CD40 ligand (CD40L). Mice with endogenous viral superantigen (SAG) delete T cells with cognate V beta independent of CD40L expression. Nevertheless, CD40L-mice do not show deletion of cognate T cells after being exposed to infectious MMTV and have greatly diminished viral replication. The response of CD40L- T cells to SAG in vitro is also impaired, but can be reconstituted by adding B cells activated by recombinant CD40L to express costimulatory molecules. Thus, direct CD40L-dependent B cell activation appears to be a critical step in the life cycle of MMTV. The initial step in SAG-dependent T cell activation, and hence the MMTV life cycle, may be mediated by non-B cells, because splenocytes from B cell-deficient SAG-transgenic mice are able to activate cognate T cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7542547     DOI: 10.1016/1074-7613(95)90166-3

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  15 in total

1.  A highly sensitive in vitro infection assay to explore early stages of mouse mammary tumor virus infection.

Authors:  S Vacheron; T Renno; H Acha-Orbea
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 2.  The hyper-IgM (HIM) syndrome.

Authors:  N Ramesh; M Seki; L D Notarangelo; R S Geha
Journal:  Springer Semin Immunopathol       Date:  1998

3.  Interleukin-4 up-regulates mouse mammary tumor virus expression yet is not required for in vivo virus spread.

Authors:  J Czarneski; J Meyers; T Peng; V Abraham; R Mick; S R Ross
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  Expression of mouse mammary tumor virus superantigen accelerates tumorigenicity of myeloma cells.

Authors:  M Umemura; W Wajjwalku; N Upragarin; T Liu; H Nishimura; T Matsuguchi; Y Nishiyama; G M Wilson; Y Yoshikai
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

5.  Role of dendritic cells in the immune response induced by mouse mammary tumor virus superantigen.

Authors:  F Baribaud; I Maillard; S Vacheron; T Brocker; H Diggelmann; H Acha-Orbea
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

6.  Immune response to mouse mammary tumor virus in mice lacking the alpha/beta interferon or the gamma interferon receptor.

Authors:  I Maillard; P Launois; I Xenarios; J A Louis; H Acha-Orbea; H Diggelmann
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

7.  Sequences within the gag gene of mouse mammary tumor virus needed for mammary gland cell transformation.

Authors:  Ingrid Swanson; Brooke A Jude; Annie R Zhang; Andrew Pucker; Zachary E Smith; Tatyana V Golovkina
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

8.  A novel block to mouse mammary tumor virus infection of lymphocytes in B10.BR mice.

Authors:  Chioma M Okeoma; Ming Shen; Susan R Ross
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

9.  Lessons Learned from Mouse Mammary Tumor Virus in Animal Models.

Authors:  Jaquelin P Dudley; Tatyana V Golovkina; Susan R Ross
Journal:  ILAR J       Date:  2016

10.  Mtv-1 superantigen trafficks independently of major histocompatibility complex class II directly to the B-cell surface by the exocytic pathway.

Authors:  M E Grigg; C W McMahon; S Morkowski; A Y Rudensky; A M Pullen
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.